Jeffrey L. Wade
2007
In 2007, Jeffrey L. Wade earned a total compensation of $805.4K as Executive Vice President and General Counsel at Lexicon Pharmaceuticals, a 20% increase compared to previous year.
Compensation breakdown
| Bonus | $130,000 |
|---|---|
| Option Awards | $352,776 |
| Salary | $316,500 |
| Other | $6,079 |
| Total | $805,355 |
Wade received $352.8K in option awards, accounting for 44% of the total pay in 2007.
Wade also received $130K in bonus, $316.5K in salary and $6.1K in other compensation.
Rankings
In 2007, Jeffrey L. Wade's compensation ranked 4,736th out of 8,700 executives tracked by ExecPay. In other words, Wade earned more than 45.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,736 out of 8,700 | 46th |
Division Manufacturing | 1,734 out of 3,314 | 48th |
Major group Chemicals And Allied Products | 355 out of 746 | 52nd |
Industry group Drugs | 217 out of 546 | 60th |
Industry Pharmaceutical Preparations | 155 out of 364 | 57th |
Source: SEC filing on March 19, 2010.
Wade's colleagues
We found four more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2007.
2007
Arthur Sands
Lexicon Pharmaceuticals
Chief Executive Officer
2007
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2007
Julia Gregory
Lexicon Pharmaceuticals
Chief Financial Officer
2007
Alan Main
Lexicon Pharmaceuticals
Executive Vice President of Pharmaceutical Research
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019